SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-22-023060
Filing Date
2022-09-26
Accepted
2022-09-26 16:07:45
Documents
1
Period of Report
2022-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3683
  Complete submission text file 0001437749-22-023060.txt   5149
Mailing Address C/O KERYX BIOPHARMACEUTICALS INC ONE MARINA PARK DRIVE BOSTON MA 02210
Business Address
ROGERS MICHAEL W (Reporting) CIK: 0001244159 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36361 | Film No.: 221265758

Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Issuer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations